Mo Shen

728 total citations
44 papers, 397 citations indexed

About

Mo Shen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mo Shen has authored 44 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Mo Shen's work include Antibiotic Resistance in Bacteria (6 papers), Bacterial biofilms and quorum sensing (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Mo Shen is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Bacterial biofilms and quorum sensing (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Mo Shen collaborates with scholars based in China, United States and Australia. Mo Shen's co-authors include Xiuling Wu, Huihui Guo, Xiang Wang, Zhanguo Chen, Wu Zhou, Tieli Zhou, Lingbo Wang, Dongqing Lv, Zhihua Tao and Wei Wei and has published in prestigious journals such as PLoS ONE, IEEE Access and Frontiers in Microbiology.

In The Last Decade

Mo Shen

33 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mo Shen China 13 186 94 61 57 55 44 397
Dongjie Chen China 12 206 1.1× 148 1.6× 88 1.4× 102 1.8× 53 1.0× 40 452
Yuqi Zhou China 18 286 1.5× 75 0.8× 32 0.5× 112 2.0× 116 2.1× 44 632
Ke Wei China 12 243 1.3× 107 1.1× 47 0.8× 34 0.6× 139 2.5× 29 516
Mai Hong Bang Vietnam 11 136 0.7× 78 0.8× 39 0.6× 64 1.1× 30 0.5× 25 377
Minyan Chen China 11 224 1.2× 69 0.7× 19 0.3× 68 1.2× 31 0.6× 34 431
Kazuaki Nomura Japan 16 211 1.1× 81 0.9× 94 1.5× 38 0.7× 101 1.8× 29 643
Tomoyuki Otani Japan 10 80 0.4× 32 0.3× 36 0.6× 49 0.9× 104 1.9× 35 338
Lan Chen China 12 212 1.1× 63 0.7× 25 0.4× 101 1.8× 128 2.3× 30 524
Zhijun Zhang China 16 311 1.7× 209 2.2× 21 0.3× 52 0.9× 33 0.6× 38 538
Alireza Farasat Iran 14 351 1.9× 37 0.4× 40 0.7× 59 1.0× 116 2.1× 43 584

Countries citing papers authored by Mo Shen

Since Specialization
Citations

This map shows the geographic impact of Mo Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Shen more than expected).

Fields of papers citing papers by Mo Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mo Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Shen. The network helps show where Mo Shen may publish in the future.

Co-authorship network of co-authors of Mo Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Mo Shen. A scholar is included among the top collaborators of Mo Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mo Shen. Mo Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Panjie, Changrui Qian, Qingxia Fu, et al.. (2025). Antimicrobial and Anti-Biofilm Activity of Dichlorophen-Functionalized Gold Nanoparticles Against Carbapenem-Resistant Enterobacteriaceae. International Journal of Nanomedicine. Volume 20. 10255–10277.
2.
Shen, Mo, Qi Wang, Qingqing Luo, Jinmin Zhao, & Feng Shen. (2025). Recent advances in phenotypic antimicrobial susceptibility testing enabled by microfluidic technologies. Sensors & Diagnostics. 5(1). 26–41.
3.
Yang, Yunke, Na Liu, Qingzhe Wu, et al.. (2025). Intratumoral heterogeneity and potential treatment strategies in small cell lung cancer. Frontiers in Oncology. 15. 1657441–1657441.
4.
Pan, Juan, et al.. (2025). Daidzein-Decorated Gold Nanoparticles as a Novel Antimicrobial Strategy Against Carbapenem-Resistant Enterobacteriaceae. International Journal of Nanomedicine. Volume 20. 7811–7827.
5.
Chen, Yuehui, et al.. (2025). Association between body roundness index and advanced cardiovascular-kidney-metabolic syndrome. Frontiers in Nutrition. 12. 1623766–1623766.
6.
Shen, Mo, et al.. (2024). A multi-scale convolutional neural network with adaptive weight fusion strategy for assisting glaucoma screening. Biomedical Signal Processing and Control. 98. 106775–106775.
8.
Mao, Xiaomin, Shumin Xu, Huan Wang, et al.. (2024). Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma. Cancer Cell International. 24(1). 173–173. 4 indexed citations
9.
Shen, Mo, et al.. (2023). Simulation of the superconducting magnet for a silicon single crystal growth. Physica C Superconductivity. 607. 1354226–1354226. 7 indexed citations
11.
Chen, Ruiqi, Meihui Li, Shuang Qin, et al.. (2023). STAT3 regulation of Mtb-specific T cell function in active pulmonary tuberculosis patients. International Immunopharmacology. 116. 109748–109748.
12.
Qin, Shuang, et al.. (2022). Dynamic monitoring of circulating CD8+ T and NK cell function in patients with septic shock. Immunology Letters. 243. 61–68. 9 indexed citations
13.
Shen, Mo, et al.. (2022). Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer. Frontiers in Oncology. 11. 780655–780655. 20 indexed citations
14.
Qin, Shuang, Yujie Jiang, Hengyue Zhu, et al.. (2021). Multifunctional T cell response in active pulmonary tuberculosis patients. International Immunopharmacology. 99. 107898–107898. 18 indexed citations
15.
Jiang, Yujie, Shuang Qin, Xin Wei, et al.. (2021). Highly activated TRAIL+ CD56bright NK cells are associated with the liver damage in HBV-LC patients. Immunology Letters. 232. 9–19. 20 indexed citations
16.
Wang, Xiang, et al.. (2015). Interaction between common variants of FTO and MC4R is associated with risk of PCOS. Reproductive Biology and Endocrinology. 13(1). 55–55. 26 indexed citations
17.
Zhou, Wu, Zhanguo Chen, Mo Shen, et al.. (2011). Association of Short Tandem Repeat Polymorphism in the Promoter of Prostate Cancer Antigen 3 Gene with the Risk of Prostate Cancer. PLoS ONE. 6(5). e20378–e20378. 15 indexed citations
18.
Tao, Zhihua, Mo Shen, Yanbo Zheng, et al.. (2010). PCA3 gene expression in prostate cancer tissue in a Chinese population: Quantification by real-time FQ-RT-PCR based on exon 3 of PCA3. Experimental and Molecular Pathology. 89(1). 58–62. 15 indexed citations
19.
Shen, Mo, Wei Chen, Zhanguo Chen, et al.. (2010). The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population. Experimental and Molecular Pathology. 90(1). 97–100. 25 indexed citations
20.
Shen, Mo. (2008). THE RESEARCH ON ANTIMICROBIAL EFFECTS OF CRUDE EXTRACTS OF CITRUS PEELS. Shipin yanjiu yu kaifa. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026